Related by context. All words. (Click for frequent words.) 60 royalty payments 56 Upfront Payment 52 RAPTIVA R 52 earnout payments 51 earnout 51 Neurogen stockholders 51 Oncolys 51 earnout provision 50 Janssen AI 50 tiered royalties 50 commercialization milestones 49 earnouts 48 Ception 48 outlicensed 48 Syncria 48 Loramyc ™ 48 non refundable deposit 47 promissory note 47 Syntonix 47 royalties 47 dacetuzumab collaboration 47 outlicensing 47 InvaGen 47 Durect 47 EpiTherapeutics 47 Milestone Payment 47 Curacyte 47 InterfeRx 47 Galephar 47 POTELLIGENT R Technology 46 AnGes 46 contingent earnout 46 Mundipharma 46 PentaStaph 46 upfront 46 codevelop 46 Metabasis stockholders 46 Genaera Liquidating Trust 46 Montaur 46 Milestone Payment From 46 Symphony GenIsis 46 Commercialization Agreement 46 AnGes MG Inc. 46 Million Milestone Payment 46 undrawn revolver 46 Contingent Consideration 46 USD1m 46 non refundable 46 subordinated promissory note 46 BBI# 46 Contingent Value Right 46 RAPTIVA r 46 Symphony Icon 46 Azimuth Opportunity Ltd. 45 Evolva 45 Revance 45 Neurimmune 45 Santaris 45 sublicense 45 Oncaspar 45 voluntary prepayment 45 LFRP 45 earnout payment 45 payment 45 Mepha AG 45 QTDP grants 45 non recourse RISPERDAL 45 USD2m 45 Bayer Schering 45 Milestone Payments 45 CFFT 45 Roche SWX ROG 45 danoprevir 45 nondividend distribution 45 convertible promissory notes 45 Option Agreement 45 CEFF financings subject 45 Celera Diagnostics joint venture 45 JT Torii 45 Nascobal 45 convertible promissory note 45 Sinuwave 45 Amended Agreement 45 commercialized DURECT 45 exclusive sublicense 45 aerosolized AAT 45 MPL adjuvant 44 PharmaBio Development 44 Tolmar Holding Inc. 44 secured promissory note 44 GlycArt 44 USD4m 44 USD5m 44 Raf kinase inhibitor 44 ZALBIN ™ 44 BioTie 44 EvaMist 44 License Agreement 44 Collaboration Agreement 44 lump sum payment 44 Agensys subsidiary 44 Zovirax ® 44 ForSight Newco II 44 Galenea 44 Ophthotech 44 MedGenesis 44 sublicensee 44 Inc ALKS 44 Unit Dose Budesonide 44 CIP TRAMADOL ER 44 indebtedness incurred 44 Astex 44 Fanapt ™ 44 OMJPI 44 Calixa 44 JUVISTA 44 AUD#.# [001] 44 HepeX B 44 Calixa Therapeutics 44 Senior Secured Term 44 MethyPatch 44 OncoMed 44 Argatroban 44 Symphony ViDA 44 gross proceeds 44 Archemix 44 Receives Milestone Payment 44 Captisol ® 44 Illumigen 44 sublicensed 44 Medigen 44 Receive Milestone Payment 44 Vernalis plc 43 convertible debenture 43 fexofenadine hydrochloride 43 Second Tranche 43 Nobex 43 generic Valtrex 43 Tranche B 43 BIIB# 43 atacicept 43 unleveraged yield 43 Rosebel royalty 43 sigma tau Group 43 ImmunoGen TAP technology 43 Amplimmune 43 EHT AGN 43 mGluR2 PAM 43 Transition Therapeutics 43 USD3m 43 secured convertible debentures 43 Agensys 43 traunch 43 S2 Therapeutics 43 elotuzumab 43 Anacor 43 Azactam 43 Kosan dependence 43 ViroChem 43 commercialize CK # 43 License Option Agreement 43 Syntonix Pharmaceuticals 43 PER.C6 r 43 Vaccinex 43 BioGeneriX 43 oral opioid modulator 43 Janssen Alzheimer Immunotherapy 43 Rinat Neuroscience 43 Debiopharm 43 BioDelivery Sciences 43 Zenotech Laboratories Ltd 43 Rheoscience 43 Miikana 43 Proprius Pharmaceuticals 43 Vimovo 43 Alnara Pharmaceuticals Inc. 43 LUCENTIS r 43 investigational atypical antipsychotic 43 Aurora kinase inhibitor 43 VaxImmune 43 Zentaris 43 Xoma 43 PharmaBio 43 Interest accrues 43 repayable contribution 43 Nippon Shinyaku 42 Angelini Labopharm 42 Esprit Pharma 42 Nascobal ® 42 Osteocel 42 Zor Pharmaceuticals 42 EvaMist TM 42 Sigma Tau Pharmaceuticals 42 Frova ® 42 QTDP 42 RYZOLT TM 42 Juvantia 42 Lexiscan ® 42 methylnaltrexone 42 Vitaros R 42 Kaketsuken 42 Dealmaking Profile 42 Phenomix 42 Wellstat Therapeutics 42 Geofine 42 secured convertible debenture 42 entity NCE 42 OTC ZEGERID 42 finder fee equal 42 Fondazione Telethon 42 BIOCEUTICALS 42 Alzheimer Immunotherapy Program 42 restricted Larrikin 42 agreement 42 apaziquone 42 refusal ROFR 42 Adnexus 42 sublicenses 42 MYL.N Quote Profile Research 42 commercialize elagolix 42 PLC ELN 42 PTH1 42 Miikana Therapeutics 42 BioAssets 42 Inc MEDX 42 USFDA approval 42 Preotact 42 ASONEP 42 Secured Convertible Debenture 42 Asentar TM 42 voluntary prepayments 42 exchangeable notes 42 research anddevelopment 42 Novexel 42 MERREM IV 42 Stedesa 42 Lung Rx 42 QTDP program 42 Alnylam RNAi 42 Acceleron Pharma Inc. 42 Novartis NVS Snapshot Report 42 sublicensing 42 n#.# [002] 42 Nasdaq ABII 42 repurchase ASR 42 La Currita Groupings 42 Indaflex 42 Kyowa Kirin 42 unconsolidated joint 42 Galore Creek Partnership 42 Inc EXEL 42 AIMM trial 42 CIMZIA r 42 ASG 5ME 42 Targeted Chemotherapy 42 Nycomed 42 Eligard ® 42 CellGate 42 RTP #i 42 RedHill 42 Lexiscan TM 42 Solzira 42 Wellstat 42 Tego Biosciences 42 Zenyaku Kogyo 42 BioOne Corporation 42 evYsio Medical Devices 42 subcutaneous RELISTOR 42 farmee 42 Cytokinetics specified 42 BioCritica 42 Nasdaq TRBN 42 promissory notes payable 42 Flutiform 42 BiolineRX 42 unsecured promissory note 42 Stavzor 42 Avian Transgenic Technology 42 Nipent 42 Aileron Therapeutics 42 Cellgate Inc. 42 pro rata portion 42 Tolerx 42 SYN X 42 Maxy G# 42 Pennsaid Plus 42 assume operatorship 41 NASDAQ SGEN 41 reborrow 41 approx. EUR 41 Reimbursable costs 41 Sanctura 41 promissory note payable 41 Licensing Agreement 41 Merz Pharmaceuticals GmbH 41 Amended Option Agreement 41 FROVA 41 Valeant Pharma 41 elbion 41 Xoma Ltd 41 XERECEPT 41 Valle del Cura 41 molecular chaperone regulation 41 Submits Biologics License Application 41 Convertible Promissory Note 41 BioInvent 41 unamortised 41 developing Zerenex ferric 41 PharmaSwiss SA 41 Fidelity Biosciences 41 Prednisporin 41 Lumacan 41 Thiakis 41 AkaRx 41 ARIKACE ™ 41 RESTASIS 41 fipamezole 41 Boehringer Ingelheim MedImmune 41 Term Loan Facility 41 NeuroMedix 41 LGLS 41 accept oversubscriptions 41 tendering noteholders 41 Lupuzor 41 Biovail Laboratories 41 SAR# [002] 41 Zegerid OTC 41 payments 41 oral contraceptives Loestrin 41 Invicorp R 41 SynthRx 41 Submits Response 41 unsecured promissory notes 41 Ambrx 41 ridaforolimus 41 Albugon 41 NASDAQ ALNY 41 overriding royalty 41 CIP ISOTRETINOIN 41 CoGenesys 41 Gastrotech 41 regulatory approval 41 pradefovir 41 subordinated promissory notes 41 USD4bn 41 USD#.#m [001] 41 ANDA abbreviated 41 LUCASSIN 41 Aloprim 41 uncollectability 41 Partnering Guide 41 unamortized deferred 41 Naglazyme R 41 Handok 41 Senior Secured Convertible 41 definitive agreements 41 Swiss drugmaker Nycomed 41 Nasdaq CRXX 41 Project QTDP 41 Bioniche Teoranta 41 sells Lotrel 41 Canadian drugmaker Aeterna 41 Sensipar R 41 Loan Facility Agreement 41 NovaCardia 41 convertible notes 41 Net Smelter Royalty 41 inhaled antibiotic 41 ALN RSV program 41 GRALISE 41 Dynepo 41 Astellas 41 Assignment Agreement 41 NitroMed stockholders 41 farmin agreement 41 Newpek LLC 41 CIP Fenofibrate 41 Furiex Pharmaceuticals 41 unvested options 41 NASDAQ NTII 41 Pennsaid R 41 Cellpep 41 SMRI 41 NASDAQ ENMD 41 Apokyn R 41 mln usd 41 Ono Pharmaceutical 41 equal installments 41 AnorMED expectation 41 Itero 41 Zeneus Holdings 41 MAXY alpha 41 j Represents 41 Opana ER 41 redeemable preference shares 41 Million Financing 41 QLT CN 41 Astex Therapeutics 41 Agenerase 41 BRL#m 41 mutually satisfactory definitive 41 Allovectin 7 R 41 Estrostep 41 DIP Loan 41 Cetirizine Hydrochloride Syrup 40 Opsona Therapeutics 40 GPR# agonist 40 OceanBASIS 40 Purchase Agreement 40 GBP#.#m [001] 40 Recothrom 40 BioMS 40 Cintra Macquarie 40 PDE4 inhibitor 40 NV Organon 40 secured convertible promissory 40 CCR2 antagonists 40 JVCo 40 unamortized financing 40 STRIANT 40 Kyowa Hakko Kirin 40 Proximagen 40 convertible preferred 40 NASDAQ RIGL 40 RxKinetix 40 Astex Therapeutics Limited 40 gross overriding royalty 40 Ultracet R 40 biosimilar insulin 40 Mitsubishi Tanabe 40 Psivida 40 Nasdaq ALNY 40 Alnylam Nasdaq ALNY 40 cicletanine 40 Montigen 40 lixivaptan 40 Xantic acquisition 40 Biolipox 40 Exclusive License 40 ZEV credits 40 Agennix Incorporated 40 CEFF 40 Apex Bioventures 40 Affitech 40 Atinum 40 Danish kroner DKK 40 ProQuin XR 40 CNP# 40 flu vaccine Influvac 40 Proteostasis 40 MacroGenics 40 Termination Agreement 40 Cashback Amount 40 Rotarix R 40 INVENT Pharmaceuticals 40 Astellas Venture 40 PF # [002] 40 promotes MERREM ® 40 Trubion Pharmaceuticals 40 commercialize telaprevir 40 cMET inhibitor 40 #,#,# warrants exercisable 40 Sensipar royalties 40 Ethyol 40 HBM BioCapital 40 Project QTDP program 40 Loramyc TM 40 Secured Loan Notes 40 Eligard R 40 Osiris retains 40 PCOP 40 joint venture 40 Abraxis 40 antiinfective 40 Xalatan 40 staphylococcal vaccines 40 Fovea Pharmaceuticals 40 Ilypsa 40 Apokyn 40 Ovation Pharmaceuticals 40 Zolpidem Tartrate Tablets 40 RAPTIVA 40 TransTech Pharma 40 Intas 40 SOLODYN R 40 Alnara Pharmaceuticals 40 CAD#.# [005] 40 sumatriptan injection 40 Pillar5 40 Orapred ODT 40 Term Facility 40 commercialization 40 unamortized portion 40 bilastine 40 Federated Kaufmann Funds 40 Cerexa Inc. 40 Urokinase 40 Labs PDLI 40 buy Qualitest Pharmaceuticals 40 AllOne Mobile Corporation 40 Inc. Nasdaq ABGX 40 Inc POZN 40 Taiho Pharmaceutical 40 NASDAQ MOGN 40 definitive documentation 40 Allovectin 7 r 40 Licenses Novel 40 warrants exercisable 40 Contingent Value Rights 40 WILEX 40 DiaPep# 40 Perlecan 40 BioSante Pharmaceuticals Announces 40 EPE unitholders 40 USD#m [001] 40 broker warrants exercisable 40 glucokinase activator 40 SansRosa 40 MorphoSys proprietary 40 RYZOLT 40 istradefylline 40 Exalgo ™ 40 Favourable Changes total 40 Oscient 40 #A COPs 40 Advinus 40 inhaled formulation 40 anti CD3 monoclonal 40 repayment 40 Campto 40 Plexxikon 40 immuno suppressant 40 orally disintegrating 40 PILT payments 40 Earns Milestone Payment 40 Montigen Pharmaceuticals 40 ratably 40 Galderma SA 40 unlevered IRR 40 tetrabenazine 40 Asentar 40 Ntotoroso Royalty 40 Strativa 40 Rs2bn 40 nonexclusive license 40 5MM 40 copromotion 40 Alantos 40 Synerx 40 TRX1 40 Rudolf Jaenisch prominent 40 QTDP grant 40 Handok Pharmaceuticals 40 Nastech Pharmaceutical 40 NanoTab 40 approved antidepressant Viibryd 40 mGluR2 positive 40 drug conjugate ADC 40 sale leaseback transaction 40 Onyx Pharma 40 BioThrax ® 40 Cornerstone BioPharma Holdings 40 COLAZAL R 40 Sumavel DosePro 40 ZCI Offer 40 Wellbutrin XL ® 40 Senior Secured Convertible Debentures 40 oral fludarabine 40 lump sum 40 RITUXAN 40 Lexiscan R 40 LX# LX# LX# 40 Aurvista 40 JunJing III 40 Cardiokine 40 Nurel 40 Proprius 40 Jaiva Technologies 40 oral nucleoside analogue 40 Non Brokered Offering 40 Subscription Amount 40 asimadoline 40 Definitive Agreement 40 Enablex 40 NDA submission 40 TKM Ebola 40 spokeswoman Marni Lemons 40 spokesman Lance Ignon 40 VentiRx 40 Sumatriptan Succinate 40 Asset Purchase Agreement 39 commonstock 39 ENZON 39 Paladin Labs 39 shares issuable upon 39 MediWound 39 Flector pain patch 39 AGTC 39 underwriting discounts commissions 39 Vantas 39 Bay Magnetite Project 39 DeveloGen 39 Estrasorb 39 Licensing Agreements 39 Sopherion Therapeutics 39 Akorn Strides 39 orphan designation 39 Roche Trimeris 39 Pierre Fabre Medicament 39 Azmacort 39 Aveo Pharmaceuticals 39 Regulus Therapeutics 39 Posidur 39 ImmunoGen maytansinoid TAP 39 asset monetizations 39 Catalyst Biosciences 39 overallotment 39 NASDAQ ISIS 39 Debt Settlement Agreements 39 PennVest loan 39 PentaLyte 39 TRACON Pharmaceuticals 39 Nanobody R 39 Prialt 39 Government Qualifying Therapeutic 39 Fanapt ® 39 Synt em 39 Zeneus 39 Requip XL 39 Secured Facility 39 Paris IPN Euronext 39 Furiex 39 Ironwood Pharmaceuticals 39 Solasia 39 Zymo 39 ACTIQ 39 Ambrosiano creditors 39 Nano Terra 39 DOV Pharmaceuticals 39 Tech DVAX 39 proprietary phage display 39 Suven 39 Hematide ™ 39 promissory notes 39 dutogliptin 39 AVINZA 39 Chromos 39 developing adecatumumab 39 CDP# 39 Gilead Sciences GILD.O 39 DKK#m [002] 39 InCentive Capital AG 39 Dificid 39 ZEGERID Capsules 39 extendible revolving 39 cofinancing 39 Factive 39 Tego IP 39 NovaQuest 39 Lamictal ODT 39 JXTC 39 Intellikine 39 BioGeneriX AG 39 Biovitrum AB 39 Pharma Medica 39 AVINZA ® 39 Gruenenthal 39 Proquin XR 39 Axordia 39 Thermadyne shareholders 39 Obtains License 39 Transcept 39 Emselex 39 promissory note receivable 39 Qualified Therapeutic Discovery 39 HZT 39 Apeiron Biologics 39 CoMentis 39 Phase lll 39 TL Nickel 39 TSE Mothers Index 39 Shire BioChem Inc. 39 FDIC indemnification 39 breakup fee 39 recognized ratably 39 ESTRASORB ® 39 AERx iDMS 39 publicy traded 39 Acapodene R 39 Rotarix ® 39 volociximab 39 BioSeek 39 Alder Biopharmaceuticals Inc. 39 SILENOR 39 Norgine BV 39 commercialize AzaSite 39 Maxipime 39 CureDM 39 miRNA therapeutics 39 Approvable letter 39 Protez 39 Ethypharm SA 39 peryear 39 Daytrana TM 39 Zeatin 39 CureTech 39 requisite regulatory approvals 39 CFSG1 receives fixed 39 L BLP# 39 CHDI Foundation 39 Oxy ER 39 Entocort 39 Royalty Payments 39 zł.#.# [003] 39 Promissory Note 39 Tramadol ER 39 Fortical ® 39 USD #mln 39 Virium 39 TOCOSOL Paclitaxel 39 Phenomix Corporation 39 Potelligent Technology 39 Optiquel ™ 39 InterfeRx license 39 Brightsource Energy 39 markets Testim ® 39 SEMOS 39 KIACTA TM 39 Active Pharmaceutical Ingredient 39 escrowed funds 39 Agreement SEDA 39 NeoGenesis 39 allowable disbursements 39 Salmedix 39 Retransmission consent revenue 39 maker Hexal AG 39 Zelapar 39 Napo Pharmaceuticals 39 ChipMOS Taiwan 39 Salishan Mohegan 39 Solazed 39 pro rata 39 Astaris joint venture 39 Initiates Phase II 39 Cellzome 39 Securities Purchase Agreement 39 VIMOVO 39 retransmission consent fees 39 solanezumab 39 amortizing 39 Acurox r Tablets 39 ALN HTT 39 ZALBIN 39 Supply Agreements 39 antidepressant Pristiq Relistor 39 AUD#.# [003] 39 P#X# antagonist 39 Flutiform TM 39 CAD#.# [001] 39 Progenics 39 PDL# 39 Mediphase Venture Partners 39 Biovail Laboratories International 39 ANDA filer 39 CAD#m [002] 39 LentiVector technology 39 Alopexx 39 refundable deposit 39 Renounceable Rights Issue 39 Sanctura XR 39 PolyTherics 39 Kenieba concessions 39 dermatological indications 39 Sanofi Aventis Allegra 39 Jin Chuang 39 GlaxoSmithKline Tykerb 39 Exelixis 39 Revance Therapeutics Inc. 39 undrawn commitments 39 Royalty Pharma 39 ZBx 39 deducting underwriting 39 Cetrotide R 39 Encysive surged 39 Pliaglis 39 Astellas Pharmaceuticals 39 Novogyne 39 DsiRNA pharmaceuticals 39 Harrah's Caesars merger 39 Raven Biotechnologies 39 Somatuline Depot 39 Addrenex 39 Impavido R 39 USD8 39 FXRE 39 Inc. NASDAQ NOVC 39 ALS Charitable Remainder 39 NASDAQ PGNX 39 TolerRx 39 fostamatinib 39 Adnexus Therapeutics 39 RESTASIS ® 39 bllion 39 Alnara 39 post doctoral fellowships 39 Kyorin Pharmaceutical 39 extendible revolving credit 39 AstraZeneca MedImmune 39 POTELLIGENT R 39 Elestrin 39 PharmaCore 39 thetransaction 39 Licence Agreement 39 Ellsin 39 ZAR#.# [005] 39 Methylphenidate Transdermal System 39 commercialize becocalcidiol patented 39 sweetness enhancer 39 Specifar 39 CapMan Buyout VIII 39 ergotamine tartrate 39 Revolving Line 39 State inherits Radmanovic 39 Targacept 39 overallotment option 39 Merck OSI Pharmaceuticals 39 Surface Specialties acquisition 39 commercialize XL# 39 Greenshoe option 39 Cutanea Life Sciences 39 Trastuzumab DM1 39 OGeS 39 Domestic Formulations 39 n#.# [001] 39 Mhakari 39 TPG Axon 39 Perforomist TM formoterol fumarate 39 EGRIFTA TM 39 Applera Applied Biosystems 39 Celgene Thalomid 39 Urocidin TM 39 theagreement 39 indemnification obligations 39 Belinostat 39 Protox 39 diabetes irritable bowel 39 BEMA Buprenorphine 39 Orphan Drug designation 39 recoupable 39 Virulizin 39 Behcet uveitis 39 Teuto 39 otelixizumab 39 Knopp Neurosciences 39 Bayer HealthCare subgroup 39 Zovirax R 39 Rexahn licensees 39 DP VPA 39 intercompany receivables 39 marketable securities totaled 39 Tyzeka Sebivo 39 LoI 39 Sanochemia 39 Preotact ® 39 Mircette R 39 USD#.#m [003] 39 Angioblast 39 DIP financing facility 39 Loan Agreement 39 Rapinyl 39 Stavzor TM 39 net smelter royalty 39 KaloBios Pharmaceuticals 39 mandatorily convertible preferred 39 Nabumetone 39 calcitonin manufacturing 39 XIAPEX 39 Nippon Kayaku 39 Chroma Therapeutics 39 Med BioGene 39 Unifill TM syringe 39 GlycoPEG GCSF 39 cinacalcet HCl 39 FCCB conversion 39 Lemtrada 39 Rottapharm Madaus 39 collaborator Bayer HealthCare 39 nonrecourse 39 Conforma 39 KuDOS Pharmaceuticals Ltd. 39 Daytrana ® 39 finders fee 39 Debt Issuance Programme 39 Secured Debentures 39 proprietary albumin fusion 39 HYLENEX recombinant 39 Bionutrics 38 Myriad logo BRACAnalysis 38 VeroScience 38 receivables securitization 38 ZAR#.# billion [002] 38 Nasdaq MITI 38 Nasdaq CGEN 38 Upper Toba Valley 38 Secured Debenture 38 Idec Roche Takeda 38 private placement 38 Asubio 38 vinorelbine emulsion 38 Exelixis logo 38 Discovery Project QTDP 38 ofapproximately 38 Jingxin Pharma 38 antitrust clearance 38 Convertible Subordinated 38 EyeTel 38 Lycera 38 Biocon insulin 38 Theragenex 38 TMGP 38 nonconvertible debt 38 Alnylam Pharmaceuticals 38 Enbrel rheumatoid arthritis 38 Uplyso 38 Letter Agreement 38 NovoNordisk 38 Fast Track Designation 38 drug Lemtrada 38 ZAR#.# [007] 38 IV APAP 38 Prospect Venture Partners 38 convertible subordinated 38 toacquire 38 convertible debenture financing 38 Biota Relenza 38 Frova R 38 Affinitak 38 SB Pharmco Puerto Rico 38 Rhein Biotech 38 Cladribine 38 undrawn revolving credit 38 Caliper Driven 38 ESML 38 millionfrom 38 ABL revolving 38 TOLMAR Holding Inc. 38 Royalty NSR 38 Arqule 38 accrued thereon 38 Onco TCS 38 AxiCorp 38 Supply Agreement 38 NovaCal 38 CovX 38 JHP Pharmaceuticals LLC 38 Genaissance 38 Corporation NASDAQ CHIR 38 SVRX 38 Zebinix R 38 ViroChem Pharma Inc. 38 Laquinimod 38 ESBATech AG 38 NeuroSolutions 38 Nycomed GmbH 38 transation 38 Arresto Biosciences 38 generic injectable 38 XOMA 3AB 38 eprodisate KIACTA TM 38 Apexigen 38 Gralise 38 LEAD Therapeutics 38 Triglide 38 Financing Agreements 38 Kedrion 38 ELND# 38 Fast Track designation 38 ProSkelia 38 FDA approvable letter 38 injectable formulation 38 NitroMed BiDil 38 bicifadine 38 EyeCyte 38 Deciphera 38 AUD1 38 Syrrx 38 FivePrime Therapeutics 38 Aryx 38 FT Units subscribed 38 compound CXA 38 Biocryst 38 Quinapril 38 generic enoxaparin 38 Pancreate 38 Polymeropoulos 38 RTO Financing 38 Avidia 38 frovatriptan 38 Humira adalimumab